descript
studi
acut
bronchiti
patient
without
preexist
pulmonari
diseas
undertaken
commun
winter
month
fortytwo
episod
investig
individu
cardin
symptom
acut
onset
ofcough
usual
product
wheez
note
patient
heard
auscult
potenti
pathogen
isol
case
viru
eight
case
identifi
frequent
either
mycoplasma
pneumonia
three
case
bacterium
three
case
acut
ill
associ
signific
reduct
forc
expir
volum
second
p
peak
expiratori
flow
p
forc
vital
capac
compar
week
later
ten
patient
histamin
challeng
test
perform
week
histamin
thirtynin
episod
treat
antibiot
gener
practition
clinic
cours
unremark
apart
one
patient
develop
lingular
pneumonia
despit
antibiot
therapi
studi
requir
assess
whether
acut
bronchiti
caus
acut
increas
bronchial
hyperrespons
whether
either
antibiot
inhal
bronchodil
antiinflammatori
therapi
use
role
manag
predominantli
viral
ill
baillir
tindal
acut
bronchiti
condit
diagnos
commonli
gener
practic
particularli
winter
month
reach
rate
approxim
case
per
popul
per
week
presum
episod
acut
bronchiti
viral
origin
although
previou
work
one
except
studi
children
patient
underli
pulmonari
diseas
shown
modest
rate
viru
identif
low
rate
bacteri
isol
also
diagnost
problem
ofidentifi
whether
individu
patient
simpl
acut
bronchiti
mani
patient
particularli
children
diagnosi
asthma
miss
believ
acut
effect
ill
pulmonari
function
minim
contribut
develop
chronic
airflow
obstruct
howev
upper
respiratori
tract
infect
may
produc
chang
pulmonari
function
indic
reduct
ga
transfer
increas
close
volum
smoker
fall
dynam
complianc
addit
uncompl
influenza
shown
produc
transient
fall
forc
expir
volum
second
arteri
oxygen
concentr
receiv
novemb
accept
may
effect
viral
infect
bronchial
hyperreact
uncertain
epidemiolog
studi
commun
give
conflict
result
respect
respiratori
tract
infect
bronchial
hyperreact
view
continu
appar
difficulti
separ
acut
bronchiti
asthma
descript
studi
undertaken
examin
clinic
microbiolog
pulmonari
function
aspect
ill
diagnos
acut
bronchiti
patient
preexist
pulmonari
diseas
patient
diagnos
acut
bronchiti
gener
practition
gp
studi
criteria
diagnosi
acut
bronchiti
given
gp
except
patient
previous
diagnos
pulmonari
diseas
exclud
studi
studi
undertaken
local
gener
practic
four
partner
practic
popul
sequenti
patient
recruit
studi
septemb
march
studi
present
week
present
demograph
data
collect
symptom
record
use
question
mrc
phl
studi
three
method
use
determin
potenti
pathogen
npw
obtain
viral
cultur
size
physiotherapi
suction
cathet
cut
distal
end
mucu
trap
insert
two
cut
end
cathet
proxim
end
cathet
attach
mechan
pump
vacuaid
model
devilbiss
health
care
patient
lie
hisher
back
neck
extend
slightli
distal
end
cathet
introduc
nare
posterior
nasopharynx
suction
commenc
ml
phosphat
buffer
salin
introduc
opposit
nare
aid
flow
back
mucu
trap
keep
specimen
moist
transfer
laboratori
wash
inocul
onto
four
cell
line
monkey
kidney
human
embryo
lung
cultur
incub
roll
minimum
week
serum
taken
present
week
later
pair
complement
fixat
test
antibodi
influenza
type
b
respiratori
syncyti
viru
rsv
adenoviru
mycoplasma
pneumonia
four
fold
rise
antibodi
titr
consid
indic
recent
infect
patient
high
titr
mpneumonia
antibodi
visit
identif
recent
infect
sought
demonstr
igm
antibodi
initi
sampl
sputum
sampl
obtain
patient
abl
produc
specimen
initi
consult
sent
routin
bacteriolog
cultur
venou
blood
taken
full
blood
count
interferon
aifn
present
serum
lge
present
week
aifn
measur
use
radioimmunoassay
method
boot
celltech
level
iuml
regard
suggest
infect
specimen
ige
separ
sera
frozen
measur
batch
end
studi
prist
techniqu
pharmacia
present
skin
prick
test
perform
cat
fur
dermatophagoid
pteronyss
lu
grass
pollen
salin
control
bencard
brentford
weal
diamet
measur
rain
mean
two
transvers
diamet
one
maximum
measur
weal
diamet
respons
mm
diamet
neg
control
regard
posit
spirometri
peak
expiratori
flow
perform
present
week
week
forc
expir
volum
second
fev
forc
vital
capac
fvc
record
use
dri
bellow
spiromet
vitalograph
throughout
studi
three
attempt
reproduc
within
made
best
fev
fvc
record
peak
expiratori
flow
pef
measur
use
wright
mini
peak
flow
meter
best
three
attempt
record
first
two
visit
respons
inhal
bronchodil
assess
repeat
measur
rain
inhal
mg
terbutalin
spacer
devic
nebuhal
astra
ltd
third
visit
week
histamin
challeng
test
hct
perform
use
yah
method
either
fall
post
salin
fev
record
maximum
dose
ofhistamin
administ
fev
use
analysi
posit
hct
regard
one
pd
fev
umol
hct
perform
patient
unabl
produc
fev
valu
reproduc
within
ml
prior
hct
patient
ask
refrain
take
bronchodil
medic
even
request
smoke
h
test
complet
test
mg
terbutalin
administ
spirometri
repeat
fev
pretest
valu
patient
hct
perform
week
ask
return
year
later
repeat
spirometri
hct
predict
valu
pulmonari
function
test
children
calcul
cote
adult
ecc
patient
age
adult
refer
tabl
use
standard
residu
sr
valueswer
calcul
adult
individu
visit
analysi
serum
ige
data
log
transform
prior
analysi
student
ttest
pair
unpair
use
appropri
analysi
chlsquar
test
fisher
exact
probabl
test
use
conting
tabl
consent
written
inform
consent
obtain
patient
studi
pass
local
ethic
committe
initi
patient
age
enter
studi
morn
even
surgeri
howev
incomplet
data
pulmonari
function
test
patient
present
pulmonari
function
even
surgeri
patient
paper
describ
result
patient
age
year
refer
studi
morn
surgeri
studi
period
fortytwo
episod
investig
patient
thirti
patient
attend
followup
appoint
four
attend
one
attend
either
followup
appoint
overal
reattend
rate
demograph
data
shown
tabl
femal
patient
predomin
ratio
mean
sd
age
whole
group
year
rang
year
twenti
episod
occur
current
cigarett
smoker
includ
two
patient
refer
twice
one
current
smoker
visit
one
current
smoker
second
visit
famili
histori
atop
diseas
case
symptom
sign
acut
onset
cough
report
patient
product
ofcas
see
fig
full
list
symptom
sign
wheez
note
patient
coryza
sore
throat
varieti
less
specif
symptom
also
report
notabl
sweat
headach
symptom
report
equal
frequenc
male
femal
clinic
sign
record
gp
case
wheez
note
crackl
ten
delay
present
gp
onset
symptom
vari
day
median
day
mean
sd
day
figur
twenti
six
patient
symptom
less
week
present
fig
current
smoker
symptom
mean
day
compar
day
nonsmok
exsmok
signific
patient
age
less
like
present
gp
within
day
onset
ill
younger
older
patient
p
virolog
bacteriolog
patient
investig
given
tabl
npw
gener
well
toler
viru
isol
seven
patient
npw
perform
present
rhinovirus
three
influenza
four
npw
perform
within
day
onset
symptom
posit
compar
three
perform
day
signific
differ
serolog
confinaa
three
influenza
infect
also
detect
one
adenoviru
npw
neg
tabl
total
white
blood
cell
count
wbcc
refer
rang
x
eight
case
test
six
patient
mildli
elev
total
white
blood
count
rang
x
two
patient
show
substanti
elev
howev
potenti
pathogen
demonstr
one
patient
total
wbcc
x
patient
tabl
posit
skin
prick
test
least
one
allergen
observ
patient
patient
year
age
significantli
like
posit
skin
prick
test
result
compar
p
one
treatment
thirtynin
episod
treat
cours
antibiot
prescrib
erythromycin
amoxycillin
plu
clavulan
acid
drug
trial
antibiot
tetracyclin
cefaclor
cotrimoxazol
amoxycillin
penicillin
v
one
patient
receiv
two
antibiot
result
pulmonari
function
test
given
tabl
mean
fev
rose
predict
present
predict
week
p
predict
histamin
challeng
test
histamin
challeng
test
perform
occas
patient
week
two
patient
present
twice
two
hct
perform
tabl
eleven
case
week
mean
sr
fev
present
patient
posit
hct
significantli
lower
mean
sr
fev
patient
neg
hct
vs
p
fig
posit
hct
week
significantli
correl
bronchodil
respons
fev
present
variabl
hct
perform
patient
nonattend
week
unabl
produc
reproduc
spirometr
curv
ischaem
heart
diseas
refus
patient
recal
repeat
hct
year
later
eighteen
patient
reattend
six
origin
posit
hct
three
remain
reactiv
one
patient
reactiv
origin
show
fev
month
later
chang
bronchial
hyperreact
two
visit
patient
within
one
doubl
dilut
except
one
patient
respiratori
tract
infect
week
prior
repeat
hct
patient
tabl
two
patient
start
inhal
steroid
gp
interven
year
patient
tabl
whose
fallen
base
weekli
return
data
year
mean
annual
attack
rate
acut
bronchiti
case
per
popul
per
week
l
hospit
inpati
enquiri
data
suggest
less
case
acut
bronchiti
admit
hospit
thu
acut
bronchiti
common
ill
manag
larg
gener
practition
weekli
return
data
acut
bronchiti
research
unit
royal
colleg
gener
practition
rurcgp
demonstr
consist
pattern
highest
attack
rise
seen
winter
month
young
elderli
age
pattern
differ
observ
present
studi
exclud
case
acut
hronchiol
exacerb
chronic
airflow
obstruct
includ
rurcgp
figur
asthma
condit
often
miss
mislabel
acut
bronchiti
gener
practic
addit
probabl
lost
case
allow
option
diagnos
chest
infect
advantag
studi
howev
patient
investig
gp
made
diagnosi
regard
acut
bronchiti
possibl
unlik
patient
may
pneumonia
present
sinc
previou
work
lower
respiratori
tract
infect
commun
exclud
clinic
pneumonia
show
new
xray
chang
patient
varieti
definit
acut
bronchiti
propos
sinc
descript
studi
chose
allow
gp
free
rein
determin
regard
acut
bronchiti
interestingli
result
mrcphl
studywher
acut
bronchiti
defin
product
cough
rhonchi
studi
strikingli
similar
fig
suggest
gener
practic
least
diagnosi
acut
bronchiti
follow
defin
line
potenti
pathogen
identifi
case
despit
short
time
sampl
inocul
cultur
less
h
find
similar
previou
studi
adult
asthma
acut
exacerb
chronic
airflow
obstruct
children
wheezi
bronchiti
three
factor
contribut
find
firstli
patient
abl
determin
durat
ofsymptom
state
symptom
present
day
sinc
viral
shed
declin
quickli
onset
infect
delay
investig
seen
studi
may
major
reason
fail
identifi
viral
pathogen
support
lack
detect
alfn
one
patient
alfn
present
transient
initi
infect
secondli
serolog
investig
perform
limit
number
respiratori
virus
major
omiss
coronavirus
usual
produc
coryz
ill
parainfluenza
virus
serolog
unreli
thirdli
suggest
sputum
might
better
sourc
viral
cultur
npw
throat
swab
studi
abl
produc
asputum
specimen
time
consult
despit
histori
product
cough
npw
well
final
possibl
attack
may
due
infect
agent
instead
might
misdiagnos
asthma
precipit
exampl
chang
temperatur
acut
bronchiti
attack
associ
environment
factor
pneumonia
infect
influenza
infect
occur
defin
outbreak
former
occur
end
recent
mycoplasma
epidem
latter
occur
novemb
decemb
influenza
infect
result
varieti
clinic
syndrom
rang
flom
seroconvers
without
overt
ill
acut
bronchiti
fulmin
pneumonia
perhap
well
recogn
caus
simpl
acut
bronchiti
bacteria
fotmd
infrequ
three
case
featur
distinguish
case
other
investig
bacteri
identif
rate
lower
studi
acut
exacerb
chronic
bronchiti
might
expect
view
colon
respiratori
tract
bacteria
patient
chronic
airway
diseas
studi
descript
natur
control
group
recruit
mrcphl
studi
includ
control
group
show
significantli
lower
microbiolog
identif
rate
individu
patient
group
believ
therefor
like
microorgan
identifi
respons
ill
popul
signific
reduct
fev
pef
improv
week
respect
whilst
chang
fvc
less
mark
find
similar
johanssen
et
al
patient
influenza
uncompl
pneumonia
patient
element
smooth
muscl
constrict
sinc
nearli
one
third
patient
bronchodil
inhal
terbutalin
present
assess
bronchial
hyperreact
bhr
perform
week
initi
present
past
patient
upper
respiratori
tract
infect
hct
perform
safe
present
sinc
found
minor
chang
pulmonari
function
feel
hct
could
perform
present
futur
studi
ideal
premorbid
hct
would
need
assess
viral
induc
chang
bhr
would
logist
major
task
hct
present
may
point
initi
even
higher
degre
reactiv
posit
hct
observ
patient
despit
exclud
patient
known
asthma
chronic
airflow
obstruct
prewtlenc
bhr
group
therefor
higher
observ
epidemiolog
studi
countri
proport
case
may
miss
asthma
degre
bronchial
hyperreact
slight
one
individu
rang
regard
moder
hyperreact
woolcock
colleagu
bronchial
hyperreact
may
transient
due
recent
infect
perform
hct
present
possibl
examin
point
close
altern
patient
bronchial
hyperreact
may
liabl
normal
individu
develop
lower
respiratori
tract
involv
viral
respiratori
tract
infect
may
individu
bronchial
irrit
syndrom
identifi
mortagi
et
al
epidemiolog
studi
would
identifi
patient
ifquest
wereask
lower
respiratori
tract
infectionssymptom
studi
ofpati
treat
antibiot
benign
outcom
one
case
lingular
pneumonia
given
antibiot
present
may
due
antibiot
reducilag
possibl
secondari
bacteri
infect
ill
induc
viru
even
rnisdiagnoscd
asthma
mani
patient
comment
inhal
terbutalin
help
eas
cough
initi
consult
may
prove
use
symptomat
treatment
studi
could
assess
whether
inhal
steroid
inhal
antiinflammatori
agent
disodium
cromoglyc
nedocromil
sodium
may
benefit
manag
inflammatori
condit
